First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

2.50
Hdl Handle:
http://hdl.handle.net/10147/246272
Title:
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Authors:
Alazzam, Mo'iad; Tidy, John; Hancock, Barry W; Osborne, Raymond; Lawrie, Theresa A
Affiliation:
Department of Gynaecology, The Galway Clinic, Doughiska, Galway, Ireland. moiad@doctors.org.uk
Citation:
First-line chemotherapy in low-risk gestational trophoblastic neoplasia. 2012, 7:CD007102 Cochrane Database Syst Rev
Journal:
Cochrane database of systematic reviews (Online)
Issue Date:
2012
URI:
http://hdl.handle.net/10147/246272
DOI:
10.1002/14651858.CD007102.pub3
PubMed ID:
22786502
Abstract:
This is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy. Most women with low-risk GTN will be cured by evacuation of the uterus with or without single-agent chemotherapy. However, chemotherapy regimens vary between treatment centres worldwide and the comparable benefits and risks of these different regimens are unclear.
Item Type:
Article
Language:
en
MeSH:
Antineoplastic Agents; Case-Control Studies; Cohort Studies; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Risk; Vitamin B Complex
ISSN:
1469-493X

Full metadata record

DC FieldValue Language
dc.contributor.authorAlazzam, Mo'iaden_GB
dc.contributor.authorTidy, Johnen_GB
dc.contributor.authorHancock, Barry Wen_GB
dc.contributor.authorOsborne, Raymonden_GB
dc.contributor.authorLawrie, Theresa Aen_GB
dc.date.accessioned2012-09-28T15:07:21Z-
dc.date.available2012-09-28T15:07:21Z-
dc.date.issued2012-
dc.identifier.citationFirst-line chemotherapy in low-risk gestational trophoblastic neoplasia. 2012, 7:CD007102 Cochrane Database Syst Reven_GB
dc.identifier.issn1469-493X-
dc.identifier.pmid22786502-
dc.identifier.doi10.1002/14651858.CD007102.pub3-
dc.identifier.urihttp://hdl.handle.net/10147/246272-
dc.description.abstractThis is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy. Most women with low-risk GTN will be cured by evacuation of the uterus with or without single-agent chemotherapy. However, chemotherapy regimens vary between treatment centres worldwide and the comparable benefits and risks of these different regimens are unclear.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Cochrane database of systematic reviews (Online)en_GB
dc.subject.meshAntineoplastic Agents-
dc.subject.meshCase-Control Studies-
dc.subject.meshCohort Studies-
dc.subject.meshDactinomycin-
dc.subject.meshDrug Administration Schedule-
dc.subject.meshFemale-
dc.subject.meshGestational Trophoblastic Disease-
dc.subject.meshHumans-
dc.subject.meshLeucovorin-
dc.subject.meshMethotrexate-
dc.subject.meshPregnancy-
dc.subject.meshRandomized Controlled Trials as Topic-
dc.subject.meshRisk-
dc.subject.meshVitamin B Complex-
dc.titleFirst-line chemotherapy in low-risk gestational trophoblastic neoplasia.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Gynaecology, The Galway Clinic, Doughiska, Galway, Ireland. moiad@doctors.org.uken_GB
dc.identifier.journalCochrane database of systematic reviews (Online)en_GB
dc.description.provinceConnachten

Related articles on PubMed

All Items in Lenus,the Irish health repository are protected by copyright, with all rights reserved, unless otherwise indicated.